PH17020A - Substituted aminothiazoles and their pharmaceutical compositions - Google Patents

Substituted aminothiazoles and their pharmaceutical compositions

Info

Publication number
PH17020A
PH17020A PH22588A PH22588A PH17020A PH 17020 A PH17020 A PH 17020A PH 22588 A PH22588 A PH 22588A PH 22588 A PH22588 A PH 22588A PH 17020 A PH17020 A PH 17020A
Authority
PH
Philippines
Prior art keywords
pharmaceutical compositions
substituted aminothiazoles
aminothiazoles
substituted
pharmaceutical
Prior art date
Application number
PH22588A
Other languages
English (en)
Inventor
Joseph George Lombardino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH17020A publication Critical patent/PH17020A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
    • F16B15/00—Nails; Staples
    • F16B15/0023—Nail plates
    • F16B2015/0076—Nail plates with provisions for additional fastening means, e.g. hooks, holes for separate screws or nails, adhesive

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH22588A 1978-06-02 1979-05-31 Substituted aminothiazoles and their pharmaceutical compositions PH17020A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91183078A 1978-06-02 1978-06-02

Publications (1)

Publication Number Publication Date
PH17020A true PH17020A (en) 1984-05-11

Family

ID=25430923

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22588A PH17020A (en) 1978-06-02 1979-05-31 Substituted aminothiazoles and their pharmaceutical compositions

Country Status (36)

Country Link
JP (1) JPS5936988B2 (de)
AR (1) AR226285A1 (de)
AT (1) AT373248B (de)
AU (1) AU511242B2 (de)
BE (1) BE876732A (de)
CA (1) CA1117949A (de)
CH (1) CH639653A5 (de)
CS (1) CS216927B2 (de)
DD (1) DD144055A5 (de)
DE (1) DE2922523C2 (de)
DK (1) DK150068C (de)
EG (1) EG14354A (de)
ES (1) ES481220A1 (de)
FI (1) FI68820C (de)
FR (1) FR2427333A1 (de)
GB (1) GB2022085B (de)
GR (1) GR73142B (de)
HK (1) HK66487A (de)
HU (1) HU180045B (de)
IE (1) IE48426B1 (de)
IL (1) IL57450A (de)
IT (1) IT1121238B (de)
KE (1) KE3459A (de)
LU (1) LU81349A1 (de)
MY (1) MY8500318A (de)
NL (1) NL178421C (de)
NO (1) NO150760C (de)
NZ (1) NZ190623A (de)
PH (1) PH17020A (de)
PL (1) PL117515B1 (de)
PT (1) PT69718A (de)
SE (1) SE438333B (de)
SG (1) SG56184G (de)
SU (1) SU843746A3 (de)
YU (1) YU40997B (de)
ZA (1) ZA792729B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001481A1 (en) * 1980-10-24 1982-05-13 Ronald P Hansen Dust mitigation system
DE3264595D1 (en) * 1981-01-08 1985-08-14 Mitsui Toatsu Chemicals N-(4-phenyl-2-thiazolyl)carbamate derivatives, process for their preparation, and medicinal composition containing same
JPS57136579A (en) * 1981-01-21 1982-08-23 Mitsui Toatsu Chem Inc Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same
JPS57116067A (en) * 1981-01-12 1982-07-19 Sankyo Kagaku Kk Novel 8-quinolinesulfonyl derivative, its synthesis and use
WO1982002386A1 (en) * 1981-01-13 1982-07-22 Sakano Isao Aminothiazole derivatives,process for their preparation,and medicinal composition containing same
EP0069154B1 (de) * 1981-01-13 1986-10-15 Mitsui Toatsu Kagaku Kabushiki Kaisha Neue thiazolverbindungen, verfahren zu deren herstellung und diese enthaltendes arzneimittel
JPS57154175A (en) * 1981-03-16 1982-09-22 Mitsui Toatsu Chem Inc 2-thiazoleamine derivative, its preparation, and drug composition comprising it
DE3227329A1 (de) * 1982-07-22 1984-01-26 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 2-n,n-disubstituierten aminothiazolen
WO1986003203A1 (fr) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Derives de thienylthiazole
FR2581063B1 (fr) * 1985-04-30 1987-07-17 Chauvin Blache Lab Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
JPS63152368A (ja) * 1986-06-03 1988-06-24 Sumitomo Pharmaceut Co Ltd 新規なアミノアゾ−ル誘導体およびその酸付加塩
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物
JPH0753666B2 (ja) * 1987-09-14 1995-06-07 久光製薬株式会社 置換ジフェニルチアゾール誘導体からなる抗炎症剤
US5463524A (en) * 1989-08-10 1995-10-31 Commonwealth Scientific And Industrial Research Organisation Producing electrosuspensions
EP0592664B1 (de) * 1991-03-07 2000-07-05 Hisamitsu Pharmaceutical Co., Inc. Diphenylthiazolderivate mit antiinflammatorischer aktivität
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
JPH10504542A (ja) * 1994-07-27 1998-05-06 ジー．ディー．サール アンド カンパニー 炎症処置用の置換チアゾール化合物
FR2754258B1 (fr) 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
JP2003525291A (ja) * 2000-03-01 2003-08-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ２，４−二置換チアゾリル誘導体
EP1423113A4 (de) * 2001-08-13 2007-04-18 Phenex Pharmaceuticals Ag Nr1h4-nuklearrezeptorbindende verbindungen
WO2003027101A1 (en) * 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors
DE60328161D1 (de) 2002-01-11 2009-08-13 Daiichi Sankyo Co Ltd Aminoalkoholderivat oder phosphonsäurederivat und diese enthaltende medizinische zusammensetzung
EP1555264A1 (de) * 2004-01-15 2005-07-20 Sireen AG Fünfringheterocyclische Verbindungen als Inhibitoren der Familie der SRC Proteinkinasen.
WO2005079788A1 (ja) 2004-02-24 2005-09-01 Sankyo Company, Limited アミノアルコール化合物
KR20080019213A (ko) 2005-05-09 2008-03-03 아칠리온 파르마세우티칼스 인코포레이티드 티아졸 화합물 및 그 사용방법
EP1981884B1 (de) 2006-01-18 2012-06-13 Amgen, Inc Thiazolverbindungen als proteinkinase b (pkb)-inhibitoren
WO2009011880A2 (en) 2007-07-17 2009-01-22 Amgen Inc. Heterocyclic modulators of pkb
WO2009011871A2 (en) 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of pkb
WO2012170951A2 (en) * 2011-06-10 2012-12-13 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2012170931A2 (en) 2011-06-10 2012-12-13 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2013059677A1 (en) 2011-10-19 2013-04-25 Calcimedica, Inc. Compounds that modulate intracellular calcium
CN110590785B (zh) * 2019-09-23 2021-02-02 武汉大学 一种氨基噻唑类化合物及其制备方法与抗肠道病毒71型的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458526A (en) * 1966-09-26 1969-07-29 Upjohn Co Certain 2-amino-4,5-bis(p-methoxyphenyl)thiazoles

Also Published As

Publication number Publication date
DK177679A (da) 1979-12-03
YU128879A (en) 1982-10-31
ES481220A1 (es) 1980-09-01
GB2022085B (en) 1983-01-12
NZ190623A (en) 1984-07-06
JPS54160369A (en) 1979-12-19
NO150760C (no) 1984-12-12
FI791754A7 (fi) 1979-11-26
CH639653A5 (fr) 1983-11-30
SG56184G (en) 1985-03-08
AU4763479A (en) 1979-12-06
IL57450A0 (en) 1979-09-30
NL7904337A (nl) 1979-12-04
BE876732A (fr) 1979-12-03
SE7904798L (sv) 1979-12-03
EG14354A (en) 1984-06-30
AU511242B2 (en) 1980-08-07
PL117515B1 (en) 1981-08-31
PT69718A (en) 1979-07-01
FI68820B (fi) 1985-07-31
LU81349A1 (fr) 1979-12-07
JPS5936988B2 (ja) 1984-09-06
GR73142B (de) 1984-02-09
IE791069L (en) 1979-12-02
SE438333B (sv) 1985-04-15
IE48426B1 (en) 1985-01-23
NO791831L (no) 1979-12-04
KE3459A (en) 1984-10-12
NL178421C (nl) 1986-03-17
NL178421B (nl) 1985-10-16
DK150068C (da) 1987-06-29
IT1121238B (it) 1986-03-26
NO150760B (no) 1984-09-03
AR226285A1 (es) 1982-06-30
PL216030A1 (de) 1980-03-10
HU180045B (en) 1983-01-28
IT7923228A0 (it) 1979-06-01
DD144055A5 (de) 1980-09-24
ATA401679A (de) 1983-05-15
YU40997B (en) 1986-10-31
FR2427333A1 (fr) 1979-12-28
IL57450A (en) 1982-11-30
CS216927B2 (en) 1982-12-31
DE2922523C2 (de) 1982-10-21
FI68820C (fi) 1985-11-11
FR2427333B1 (de) 1983-05-20
MY8500318A (en) 1985-12-31
HK66487A (en) 1987-09-25
ZA792729B (en) 1981-03-25
DK150068B (da) 1986-12-01
SU843746A3 (ru) 1981-06-30
CA1117949A (en) 1982-02-09
GB2022085A (en) 1979-12-12
DE2922523A1 (de) 1979-12-06
AT373248B (de) 1983-12-27

Similar Documents

Publication Publication Date Title
PH17020A (en) Substituted aminothiazoles and their pharmaceutical compositions
NZ189378A (en) 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions
NZ190784A (en) Benzofuranyl-piperidines and pharmaceutical compositions
GB2039738B (en) Inflammation - preventing pharmaceutical composition
NZ189438A (en) Perhaloalkylvinylcyclopropanecarboxylates intermediates and pharmaceutical compositions
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
GB2038818B (en) Dihydropolyprenyl alcohols and pharmaceutical compositions thereof
IL56908A0 (en) N-oxacyclic alcylpiperidyl-diaza compounds their manufactuure and pharmaceutical compositions containig them
IL56577A (en) Pharmaceutical compositions comprising certain 1-substituted-2-pyrrolidinones
IL58415A0 (en) Phenyl-quinolizidines their manufacture and pharmaceutical compositions containing them
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
NZ191556A (en) Aurone derivatives and pharmaceutical compositions
NZ190521A (en) Phenylamino-thiophenacetic acids and pharmaceutical compositions
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
GB2034587B (en) Pharmaceutical compositions
NZ192142A (en) Cephalosporin derivatives and pharmaceutical compositions
GB2039218B (en) Pharmaceutical compositions
GB2031727B (en) Pharmaceutical compositions
NZ189769A (en) Benzylidene derivatives and pharmaceutical compositions
NZ189279A (en) Arylaminoimidazolines and pharmaceutical compositions
JPS54154516A (en) Pharmaceutical composition
NZ190293A (en) Benzimidoyl-piperazines and pharmaceutical compositions
IL57882A0 (en) 2-thiophenecarboxamido-alkylmercaptans and pharmaceutical compositions containing them
NZ190007A (en) Steroid-spiro-oxazolidinone derivatives and pharmaceutical compositions
NZ190665A (en) S-benzylcysteine derivatives and pharmaceutical compositions